when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

calendar

1,546 catalysts · 3,350 8k filing · 2,043 grant · 1,000 device adverse event · 962 approval · 696 device 510k · 584 earnings

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

sort

soonest latest type sponsor alpha

type: approval×type: earnings×from 2026-01-25×clear all

search

type

8k filing3,350
grant2,043
device adverse event1,000
approval962
device 510k696
earnings584

device pma

521

device recall231

phase 2 completion172

therapy area

no tagged catalysts yet

Week of Jan 19, 2026

7

›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jan 25, 2026approval202d agoCLOZAPINE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Week of Jan 26, 2026

43

›Jan 26, 2026approval201d agoAMLODIPINE BESYLATE — FDA approvalGraviti Pharmaceuticals Inc

Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jan 26, 2026approval

← prev

page 1 of 31

201d ago

BETAMETHASONE DIPROPIONATE — FDA approvalBETAMETHASONE DIPROPIONATE

Sponsor: AUROBINDO PHARMA LTD. Form: CREAM. Route: TOPICAL

full page →BETAMETHASONE DIPROPIONATE →fda approvals ↗

›Jan 26, 2026approval201d agoPALIPERIDONE — FDA approvalpaliperidone ER

Sponsor: APOTEX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →paliperidone ER →fda approvals ↗

›Jan 26, 2026approval201d agoMETHYLPREDNISOLONE ACETATE — FDA approvalPFIZER INC

Sponsor: CAPLIN. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

›Jan 26, 2026approval201d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

›Jan 26, 2026approval201d agoFINASTERIDE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jan 26, 2026approval201d agoCHLORPROMAZINE HYDROCHLORIDE — FDA approvalCHLORPROMAZINE HYDROCHLORIDE

Sponsor: MSN. Form: INJECTABLE. Route: INJECTION

full page →CHLORPROMAZINE HYDROCHLORIDE →fda approvals ↗

›Jan 26, 2026approval201d agoTRANEXAMIC ACID — FDA approvalHyloris Pharmaceuticals SA

Sponsor: I 3 PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jan 26, 2026approval201d agoDIFLUPREDNATE — FDA approvalDIFLUPREDNATE

Sponsor: ALEMBIC. Form: EMULSION. Route: OPHTHALMIC

full page →DIFLUPREDNATE →fda approvals ↗

›Jan 26, 2026approval201d agoTAPENTADOL HYDROCHLORIDE — FDA approvaltapentadol hydrochloride ER

Sponsor: NOVITIUM PHARMA. Form: SOLUTION. Route: ORAL

full page →tapentadol hydrochloride ER →fda approvals ↗

›Jan 26, 2026approval201d agoDAPTOMYCIN — FDA approvalDaptomycin Novo

Sponsor: ACCORD HLTHCARE. Form: POWDER. Route: INTRAVENOUS

full page →Daptomycin Novo →fda approvals ↗

›Jan 26, 2026approval201d agoBUDESONIDE — FDA approvalbudesonide DR

Sponsor: RISING. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

full page →budesonide DR →fda approvals ↗

›Jan 26, 2026approval201d agoQUIOFIC (FOLIC ACID) — FDA approvalfolic acid

Sponsor: SOLUBIOMIX. Form: SOLUTION. Route: ORAL

full page →folic acid →fda approvals ↗

›Jan 26, 2026approval201d agoCUPRIC CHLORIDE — FDA approvalCUPRIC CHLORIDE

Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

full page →CUPRIC CHLORIDE →fda approvals ↗

›Jan 27, 2026approval200d agoDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval(daratumumab + hyaluronidase (human recombinant))

Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

full page →(daratumumab + hyaluronidase (human recombinant)) →fda approvals ↗

›Jan 27, 2026approval200d agoNOXAFIL POWDERMIX KIT (POSACONAZOLE) — FDA approvalPOSACONAZOLE

Sponsor: MSD MERCK CO. Form: FOR SUSPENSION, DELAYED RELEASE. Route: ORAL

full page →POSACONAZOLE →fda approvals ↗

›Jan 27, 2026approval200d agoTAPENTADOL HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: HUMANWELL. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jan 27, 2026approval200d agoNOXAFIL (POSACONAZOLE) — FDA approvalPOSACONAZOLE

Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

full page →POSACONAZOLE →fda approvals ↗

›Jan 27, 2026approval200d agoFIDAXOMICIN — FDA approvalDificid

Sponsor: TORRENT. Form: TABLET. Route: ORAL

full page →Dificid →fda approvals ↗

›Jan 27, 2026approval200d agoVYXEOS (CYTARABINE) — FDA approvalMeitheal Pharmaceuticals Inc

Sponsor: JAZZ PHARMS THERAP. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

›Jan 27, 2026approval200d agoMESNA — FDA approvalRiconpharma LLC

Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

›Jan 27, 2026approval200d agoTOPIRAMATE — FDA approvaltopiramate ER

Sponsor: NATCO. Form: TABLET. Route: ORAL

full page →topiramate ER →fda approvals ↗

›Jan 27, 2026approval200d agoPROPRANOLOL HYDROCHLORIDE — FDA approvalpropranolol hydrochloride ER

Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL

full page →propranolol hydrochloride ER →fda approvals ↗

›Jan 27, 2026approval200d agoIDOSE TR (TRAVOPROST) — FDA approvalTRAVOPROST

Sponsor: GLAUKOS. Form: IMPLANT. Route: INTRACAMERAL

full page →TRAVOPROST →fda approvals ↗

›Jan 27, 2026approval200d agoIDOSE TR (TRAVOPROST) — FDA approvalTRAVOPROST

Sponsor: GLAUKOS. Form: IMPLANT. Route: INTRACAMERAL

full page →TRAVOPROST →fda approvals ↗

›Jan 27, 2026approval200d agoNOXAFIL (POSACONAZOLE) — FDA approvali3 Pharmaceuticals LLC

Sponsor: SCHERING. Form: SUSPENSION. Route: ORAL

full page →fda approvals ↗

›Jan 27, 2026approval200d agoCAPECITABINE — FDA approvalArmas Pharmaceuticals Inc

Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jan 27, 2026approval200d agoCAPRELSA (VANDETANIB) — FDA approvalvandetanib

Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL

full page →vandetanib →fda approvals ↗

›Jan 27, 2026approval200d agoPRIFTIN (RIFAPENTINE) — FDA approvalrifapentine

Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

full page →rifapentine →fda approvals ↗

›Jan 27, 2026approval200d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

›Jan 27, 2026approval200d agoDEFLAZACORT — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: SUN PHARM INDS INC. Form: SUSPENSION. Route: ORAL

full page →fda approvals ↗

›Jan 27, 2026approval200d agoNOXAFIL (POSACONAZOLE) — FDA approvalPOSACONAZOLE

Sponsor: MERCK SHARP DOHME. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →POSACONAZOLE →fda approvals ↗

›Jan 28, 2026approval199d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

full page →fda approvals ↗

›Jan 28, 2026approval199d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

›Jan 28, 2026approval199d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

Sponsor: PF PRISM CV. Form: FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

›Jan 28, 2026approval199d agoALENDRONATE SODIUM — FDA approvalALENDRONATE SODIUM

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →ALENDRONATE SODIUM →fda approvals ↗

›Jan 28, 2026approval199d agoALENDRONATE SODIUM — FDA approvalALENDRONATE SODIUM

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →ALENDRONATE SODIUM →fda approvals ↗

›Jan 28, 2026approval199d agoYUVEZZI (BRIMONIDINE TARTRATE) — FDA approvalBausch & Lomb Corp

Sponsor: VISUS. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →fda approvals ↗

›Jan 28, 2026approval199d agoDAYSEE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL

full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗

›Jan 28, 2026approval199d agoISOSULFAN BLUE — FDA approvalISOSULFAN BLUE

Sponsor: MYLAN INSTITUTIONAL. Form: SOLUTION. Route: SUBCUTANEOUS

full page →ISOSULFAN BLUE →fda approvals ↗

›Jan 28, 2026approval199d agoCLOMIPRAMINE HYDROCHLORIDE — FDA approvalTruPharma LLC

Sponsor: TARO. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

›Jan 28, 2026approval199d agoABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalaripiprazole LA

Sponsor: OTSUKA PHARM CO LTD. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

full page →aripiprazole LA →fda approvals ↗

›Jan 28, 2026approval199d agoSERTRALINE HYDROCHLORIDE — FDA approvalSERTRALINE HYDROCHLORIDE

Sponsor: AMNEAL. Form: CAPSULE. Route: ORAL

full page →SERTRALINE HYDROCHLORIDE →fda approvals ↗

$MRK135.84+0.21%

$AMRX18.15+5.10%

$AMRX18.15+5.10%

$PFE26.79-0.06%

$AMRX18.15+5.10%

$AMRX18.15+5.10%

$BLCO16.980.00%

$COLL28.23+0.28%

$GKOS186.17-1.73%

$GKOS186.17-1.73%